1- Department of Psychiatry, Faculty of Medicine, Research Center of Addiction and Risky Behavior, Iran University of Medical Sciences, Tehran, Iran.
2- Department of Psychiatry, Iran University of Medical Sciences, Tehran, Iran.
3- Department of Psychiatry, Faculty of Medicine, Research Center of Addiction and Risky Behavior, Iran University of Medical Sciences, Tehran, Iran. , m.faramarzi89@yahoo.com
Abstract: (3539 Views)
Synthetic cannabinoids (SC) are a heterogeneous group of substances with a high affinity for cannabinoid receptors. Unlike Δ9-tetrahydrocannabinol (THC), synthetic cannabinoids are incredibly potent, highly productive, have more affinity for the cannabinoid receptor type 1 (CB1), and cannabinoid receptor type 2 (CB2), and are designed to accelerate the effects of tetrahydrocannabinol. Also, there is experimental evidence that SCs act on non-cannabinoid receptors, such as the 5-HT2B receptor or dopaminergic receptors.
Type of Study:
Letter to the editor |
Subject:
Psychiatry and Psychology Received: 2021/08/9 | Accepted: 2021/11/29 | Published: 2022/04/20